Overview
Status
Active
Registry date
2018-06-14
Share capital
150,000.00 PLN
Registered address
al. Grunwaldzka 56/113, 80-241 Gdańsk, Poland
Email
Financials
Total Operating Costs
328.74k
+953.6% vs 2020
Revenue history (in k)
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 698 days for 2019).
- 2022not filed
- 202113/09/2022
- 202013/09/2022
- 201913/09/2022
- 201812/07/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2021.
Results vs industry
Revenue
This companyUSD 328.86kMedianUSD 164.14kAverageUSD 2.27m
Net profit
This companyUSD 109.31MedianUSD 1.03kAverageUSD 108.21k
Operating costs
This companyUSD 328.74kMedianUSD 187.05kAverageUSD 2.07m
Assets
This companyUSD 38.93kMedianUSD 115.76kAverageUSD 1.52m
Industry
Authorized Representatives
Seweryn Sroka – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Seweryn Srokaage 44 | 100 | $40,518.64 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2021-03-25 to 2023-04-26.
Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)
Debt
2 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jun 6, 2024 | Discontinued enforcement proceedings | Closed | |
| Dec 22, 2023 | Discontinued enforcement proceedings | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 2, 2025 | Dissolution without liquidation opened | |
| Nov 20, 2023 | Dissolution without liquidation opened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 14, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Starosta Powiatu Tarnobrzeg |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Zakłady Farmaceutyczne PolpharmaS.A. | $780,704,907.94 | polpharma.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-03-19 | Address change (Ul. Władysława Łokietka 57, 39-400, Tarnobrzeg → Al. Grunwaldzka 56/113, 80-241, Gdańsk) | |
| 2021-03-19 | PKD change (Removed: 4 codes; Added: 4 codes) | |
| 2019-12-09 | Address change (Ul. Stanisława Wyspiańskiego 8/41, 39-400, Tarnobrzeg → Ul. Władysława Łokietka 57, 39-400, Tarnobrzeg) | |
| 2018-06-14 | Entered in the register |
FAQ
The main business activity of Breka focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on June 14, 2018.
The headquarters is located at: Al. Grunwaldzka 56, 80-241 Gdańsk.
The management board consists of: Seweryn Sroka (President of the Management Board).
The share capital of the company is PLN 150,000 (approx. $40,519).
The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.
Last updated: 2026-10-07